Factors Associated with Adolescents' Choice to Use Long Acting Reversible Contraceptives: a Systematic Review

Imagem de Miniatura
Arquivos
art_REIS_Factors_Associated_with_Adolescents_Choice_to_Use_Long_2018.PDF (498.11 KB)
Citações na Scopus
Tipo de produção
article
Data de publicação
2018
DOI
Web of Science
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
VILELA, Ana Luiza
ABREU, Luiz Carlos de
Citação
CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, v.7, n.4, p.153-162, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose of ReviewThis review aims to update the published literature to summarize our understanding about the associated factors with adolescents' willingness to use long-acting reversible contraceptives.Recent FindingsLong acting reversible contraception (LARCs), specifically intrauterine devices and implants, have been successful in preventing unintended pregnancy and repeat pregnancy among adolescents. Unfortunately, many misconceptions about eligibility, fears of the insertion procedure, and health effects prevent adolescents from choosing them.SummaryA total of 1316 articles were identified and only nine met the inclusion criteria. Included studies reported findings on 12,851 adolescents aged 12 to 19years old, revealing many correlates like the knowledge/information about these contraceptives, age, marital status, and cultural aspects. Few articles compared the correlates of choosing intrauterine devices versus implants. All articles presented studies performed in contexts where access barriers to contraceptives were removed, including the costs. In the future, it could prove useful to develop a study that could compare types of LARCs, as well as in an exclusive adolescent population in different countries. It would also be helpful to compare adolescents' use in low- and middle-income countries, and in different contexts with limited access to family planning services and contraceptives.
Palavras-chave
Adolescents, Willingness to use, Choice, Long acting reversible contraception, Intrauterine devices, Subdermal implants
URI
https://observatorio.fm.usp.br/handle/OPI/29991
Referências
  1. Abma Joyce C, 2017, Natl Health Stat Report, P1
  2. Abraham M, 2015, OBSTET GYNECOL, V126, P823, DOI 10.1097/AOG.0000000000001036
  3. [Anonymous], 2015, KEY DAT AD 2015
  4. [Anonymous], 2015, GLOB CONS STAT EXP C
  5. Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0347-9
  6. Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1
  7. Comm Adolescent Hlth Care, 2018, OBSTET GYNECOL, V131, pE130, DOI 10.1097/AOG.0000000000002632
  8. Darroch JE, 2016, ADDING IT COSTS BENE
  9. Diedrich JT, 2017, AM J OBSTET GYNECOL, V216, P364, DOI 10.1016/j.ajog.2016.12.024
  10. Donnelly KZ, 2014, CONTRACEPTION, V90, P280, DOI 10.1016/j.contraception.2014.04.012
  11. Sorpreso ICE, 2015, REV BRAS GINECOL OBS, V37, P395, DOI 10.1590/SO100-720320150005456
  12. Fikree FF, 2017, AFR J REPROD HEALTH, V21, P37, DOI 10.29063/ajrh2017/v21i3.3
  13. Frost JJ, 2012, PERSPECT SEX REPRO H, V44, P107, DOI 10.1363/4410712
  14. Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0
  15. Harris K, 2016, J PRIM CARE COMMUNIT, V7, P76, DOI 10.1177/2150131915621058
  16. Hoopes AJ, 2016, J PRIM CARE COMMUNIT, V7, P165, DOI 10.1177/2150131916641095
  17. Hoopes AJ, 2016, J PEDIATR ADOL GYNEC, V29, P259, DOI 10.1016/j.jpag.2015.09.011
  18. Jatlaoui TC, 2017, CONTRACEPTION, V95, P17, DOI 10.1016/j.contraception.2016.10.006
  19. Kavanaugh ML, 2013, J PEDIATR ADOL GYNEC, V26, P86, DOI 10.1016/j.jpag.2012.10.006
  20. Kavanaugh ML, 2013, J ADOLESCENT HEALTH, V52, P284, DOI 10.1016/j.jadohealth.2012.10.276
  21. Lantos H, 2016, J ADOLESCENT HEALTH, V58, P644, DOI 10.1016/j.jadohealth.2016.03.006
  22. Lohr PA, 2017, CONTRACEPTION, V95, P529, DOI 10.1016/j.contraception.2016.08.011
  23. Madden T, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.928
  24. Manlove J, 2007, DEMOGRAPHY, V44, P603, DOI 10.1353/dem.2007.0031
  25. Mesheriakova VV, 2017, CLIN PEDIATR, V56, P1227, DOI 10.1177/0009922816681135
  26. Mestad R, 2011, CONTRACEPTION, V84, P493, DOI 10.1016/j.contraception.2011.03.001
  27. Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
  28. Moreau C, 2007, CONTRACEPTION, V76, P267, DOI 10.1016/j.contraception.2007.06.008
  29. [Organization WH. Organization WH], 1989, THE HLTH OF YOUTH
  30. Peipert JF, 2011, OBSTET GYNECOL, V117, P1105, DOI 10.1097/AOG.0b013e31821188ad
  31. Polis C, 2016, CONTRACEPTIVE FAILUR
  32. Pritt NM, 2017, J PEDIATR ADOL GYNEC, V30, P18, DOI 10.1016/j.jpag.2016.07.002
  33. Saavedra-Avendano B, 2017, MATERN CHILD HLTH J, V21, P1724, DOI 10.1007/s10995-016-2013-1
  34. Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506
  35. Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017
  36. Spies EL, 2010, WOMEN HEALTH ISS, V20, P394, DOI 10.1016/j.whi.2010.07.005
  37. Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
  38. Tsikouras P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020348
  39. Whitaker AK, 2010, J PEDIATR ADOL GYNEC, V23, P116, DOI 10.1016/j.jpag.2009.09.012
  40. WHO, 2015, LIB CAT IN PUBL DAT

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/58